A floxed allele of the androgen receptor gene causes hyperandrogenization in male mice

Physiological Genomics

Volumn 33, Issue 1, 2008, Pages 133-137

  MacLean, Helen E ^a   Chiu, W S Maria ^a   Ma, Cathy ^a   McManus, Julie F ^a   Davey, Rachel A ^a   Cameron, Rhoda ^b   Notini, Amanda J ^a   Zajac, Jeffrey D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Androgen; Androgen insensitivity; Cre lox; Hypomorphic allele; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; MESSENGER RNA; TESTOSTERONE;

ALLELE; ANDROGEN RECEPTOR GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; HEART; HISTOLOGY; HYPERANDROGENIZATION; KIDNEY; LEVATOR ANI MUSCLE; MALE; MALE FERTILITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEMINAL VESICLE; SPERMATOGENESIS; TESTIS; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

ANIMALS; BODY WEIGHT; CROSSES, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HEART; HYPERANDROGENISM; INTEGRASES; KIDNEY; LIVER; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; RECEPTORS, ANDROGEN; RNA, MESSENGER; TESTIS; TESTOSTERONE;

MUS;

EID: 41349102569     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00260.2007     Document Type: Article

References (28)

1. Axell AM, MacLean HE, Plant DR, Harcourt LJ, Davis JA, Jimenez M, Handelsman DJ, Lynch GS, Zajac JD. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab 291: E506-E516, 2006.
2. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569, 1998.
3. Burns KH, Matzuk MM. Minireview: genetic models for the study of gonadotropin actions. Endocrinology 143: 2823-2835, 2002.
4. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110: 639-648, 2002.
5. Davey RA, MacLean HE. Current and future approaches using genetically modified mice in endocrine research. Am J Physiol Endocrinol Metab 291: E429-E438, 2006.
6. Davey RA, MacLean HE, McManus JF, Findlay DM, Zajac JD. Genetically modified animal models as tools for studying bone and mineral metabolism. J Bone Miner Res 19: 882-892, 2004.
7. De Gendt K, Atanassova N, Tan KA, de Franca LR, Parreira GG, McKinnell C, Sharpe RM, Saunders PT, Mason JI, Hartung S, Ivell R, Denolet E, Verhoeven G. Development and function of the adult generation of Leydig cells in mice with Sertoli cell-selective or total ablation of the androgen receptor. Endocrinology 146: 4117-4126, 2005.
8. Fedorov LM, Haegel-Kronenberger H, Hirchenhain J. A comparison of the germline potential of differently aged ES cell lines and their transfected descendants. Transgenic Res 6: 223-231, 1997.
9. Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Cancer Invest 25: 32-37, 2007.
10. Gottlieb B, Beitel LK, Wu JH, Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23: 527-533, 2004.
11. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab 77: 776-779, 1993.
12. Holdcraft RW, Braun RE. Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids. Development 131: 459-467, 2004.
13. Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, Domenighetti AA, Dunn A, Ernst M, Grail D, Fodero-Tavoletti M, Huggins CE, Delbridge LM, Zajac JD, Proietto J. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 31: 449-459, 2003.
14. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91: 843-850, 2006.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001.
16. Makinen JI, Perheentupa A, Irjala K, Pollanen P, Makinen J, Huhtaniemi I, Raitakari OT. Endogenous testosterone and serum lipids in middle-aged men. Atherosclerosis (June 21, 2007). doi:10.1016/j.atherosclerosis. 2007.05.009.
17. Notini AJ, Davey RA, McManus JF, Bate KL, Zajac JD. Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model. J Mol Endocrinol 35: 547-555, 2005.
18. Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WS, Glatt V, Kream BE, Handelsman DJ, Morris HA, Zajac JD, Davey RA. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res 22: 347-356, 2007.
19. Nott A, Meislin SH, Moore MJ. A quantitative analysis of intron effects on mammalian gene expression. RNA 9: 607-617, 2003.
20. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271-321, 1995.
21. Raffai RL, Weisgraber KH. Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biol Chem 277: 11064-11068, 2002.
22. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66: 2815-2825, 2006.
23. Tan KA, De Gendt K, Atanassova N, Walker M, Sharpe RM, Saunders PT, Denolet E, Verhoeven G. The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total or Sertoli cell-selective ablation of the androgen receptor. Endocrinology 146: 2674-2683, 2005.
24. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777-3782, 1997.
25. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85: 3276-3282, 2000.
26. Waters ST, Lewandoski M. A threshold requirement for Gbx2 levels in hindbrain development. Development 133: 1991-2000, 2006.
27. Yang J, Goldstein JL, Hammer RE, Moon YA, Brown MS, Horton JD. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc Natl Acad Sci USA 98: 13607-13612, 2001.
28. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91: 4335-4343, 2006.